PTP-001

Bioventus LLC · Phase 2 active Biologic

At a glance

Generic name	PTP-001
Sponsor	Bioventus LLC
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (PHASE3)
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis (PHASE2)
Safety Study of PTP-001 for Treating Knee Osteoarthritis (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PTP-001 CI brief — competitive landscape report
PTP-001 updates RSS · CI watch RSS
Bioventus LLC portfolio CI